Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Aromatic organic compounds that consist of a phenyl functional group (−C6H5) bonded to a hydroxyl functional group (−OH). Includes compounds with more substitutions and derivatives.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Bupivacaine hydrochloride is an NMDA receptor inhibitor that can also block sodium, L-calcium, and potassium channels. It potently blocks SCN5A channels with an IC50 of 69.5 μM. This compound is suitable for research related to chronic pain.
NMDA receptor inhibitor.
Blocks sodium, L-calcium, and potassium channels.
Potent blocker of SCN5A channels.
Useful for chronic pain research.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Oxyphencyclimine hydrochloride is a new tertiary amine that has been investigated for its effects on the peripheral parasympathetic system. This product is intended for research and analytical applications.
A new tertiary amine
Investigated for effects on the peripheral parasympathetic system
Solid appearance
White to off-white color
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Luvixasertib hydrochloride is the hydrochloride salt of luvixasertib, a highly selective and orally bioavailable inhibitor of the TTK/Mps1 protein kinase. It is used in preclinical cancer research to probe spindle assembly checkpoint biology and to evaluate therapeutic potential against TTK-dependent tumors; reported enzymatic potency is approximately IC50 1.7 nM.